Company / R&D per Share
Orthofix Medical Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.08
FY2025
5-year range
$1.32 / $2.46
FY2021-FY2025
Trend
+57.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $2.46 to $2.08 over the past 2 years.
Based on SEC 10-K filings.
2.08 in FY2025 with a 5-year CAGR of +3.6%.
Declined from $2.46 to $2.08 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +1.9%
- 5-Year CAGR
- +3.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 57.9% year-over-year.
- Peak r&d per share was recorded in FY2023.
- Lowest r&d per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.08 | +57.9% |
| FY2024 | $1.32 | -46.4% |
| FY2023 | $2.46 | +25.0% |
| FY2022 | $1.97 | +10.4% |
| FY2021 | $1.78 | +2.1% |
| FY2020 | $1.75 | +9.2% |
| FY2019 | $1.60 | +1.4% |
| FY2018 | $1.58 | +6.5% |
| FY2017 | $1.48 | +10.5% |
| FY2016 | $1.34 | -6.9% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 28, 2026